Published in Invest Ophthalmol Vis Sci on April 01, 1998
A look at autoimmunity and inflammation in the eye. J Clin Invest (2010) 2.30
Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates. Nat Rev Immunol (2013) 1.39
The living eye "disarms" uncommitted autoreactive T cells by converting them to Foxp3(+) regulatory cells following local antigen recognition. J Immunol (2012) 1.18
The adaptive immune system in diseases of the central nervous system. J Clin Invest (2012) 1.17
Understanding autoimmune uveitis through animal models. The Friedenwald Lecture. Invest Ophthalmol Vis Sci (2011) 1.11
Mechanisms of leukocyte migration across the blood-retina barrier. Semin Immunopathol (2008) 1.09
The role of complement in ocular pathology. Semin Immunopathol (2008) 1.07
New perspectives on effector mechanisms in uveitis. Semin Immunopathol (2008) 1.02
Photoreceptor mitochondrial oxidative stress in early experimental autoimmune uveoretinitis. Br J Ophthalmol (2006) 1.02
Identification of novel dendritic cell populations in normal mouse retina. Invest Ophthalmol Vis Sci (2007) 1.01
Nitric oxide mediates apoptosis through formation of peroxynitrite and Fas/Fas-ligand interactions in experimental autoimmune uveitis. Am J Pathol (2002) 1.00
Resting CD8 T cells recognize beta-galactosidase expressed in the immune-privileged retina and mediate autoimmune disease when activated. Immunology (2003) 0.91
Immune mechanisms in inflammatory and degenerative eye disease. Trends Immunol (2015) 0.90
Lymphopenia-induced proliferation is a potent activator for CD4+ T cell-mediated autoimmune disease in the retina. J Immunol (2009) 0.89
A new look at immune privilege of the eye: dual role for the vision-related molecule retinoic acid. J Immunol (2011) 0.88
Lack of inducible nitric oxide synthases attenuates leukocyte-endothelial cell interactions in retinal microcirculation. Br J Ophthalmol (2008) 0.86
Lipopolysaccharide/interferon-gamma and not transforming growth factor beta inhibits retinal microglial migration from retinal explant. Br J Ophthalmol (2003) 0.86
Peripheral induction of tolerance by retinal antigen expression. J Immunol (2009) 0.86
Retinal S-antigen Th1 cell epitope mapping in patients with Behcet's disease. Graefes Arch Clin Exp Ophthalmol (2008) 0.84
Abrogation of anti-retinal autoimmunity in IL-10 transgenic mice due to reduced T cell priming and inhibition of disease effector mechanisms. J Immunol (2008) 0.84
Adoptive transfer of immune cells from glaucomatous mice provokes retinal ganglion cell loss in recipients. Acta Neuropathol Commun (2015) 0.82
Tertiary Lymphoid Tissue Forms in Retinas of Mice with Spontaneous Autoimmune Uveitis and Has Consequences on Visual Function. J Immunol (2015) 0.81
Retina-specific T regulatory cells bring about resolution and maintain remission of autoimmune uveitis. J Immunol (2015) 0.80
Scanning laser ophthalmoscopy and fundus fluorescent leucocyte angiography. Br J Ophthalmol (1999) 0.78
Upregulation of DR3 expression in CD4⁺ T cells promotes secretion of IL-17 in experimental autoimmune uveitis. Mol Vis (2011) 0.76
Modelling experimental uveitis: barrier effects in autoimmune disease. Inflamm Res (2012) 0.75
Inducible co-stimulator (ICOS) is upregulated in experimental autoimmune uveoretinitis. Graefes Arch Clin Exp Ophthalmol (2006) 0.75
Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol (1995) 2.87
High-resolution histologic analysis of the human choroidal vasculature. Invest Ophthalmol Vis Sci (1994) 2.64
T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. J Immunol (1986) 2.55
Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues. Proc Natl Acad Sci U S A (1988) 2.34
Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol (1990) 2.13
Retinal hypoxia in long-term diabetic cats. Invest Ophthalmol Vis Sci (1998) 1.77
Pathology of experimental autoimmune uveoretinitis in mice. J Autoimmun (1990) 1.71
Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial. Am J Ophthalmol (1997) 1.71
Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. J Exp Med (1999) 1.70
Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype. Invest Ophthalmol Vis Sci (2000) 1.68
IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J Immunol (1997) 1.68
Increase in the advanced glycation end product pentosidine in Bruch's membrane with age. Invest Ophthalmol Vis Sci (1999) 1.67
Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol (1996) 1.65
Choriocapillaris degeneration and related pathologic changes in human diabetic eyes. Arch Ophthalmol (1998) 1.64
Heterogeneity in localization of isoforms of TGF-beta in human retina, vitreous, and choroid. Invest Ophthalmol Vis Sci (1993) 1.61
A new technique for visualization of the human retinal vasculature. Arch Ophthalmol (1992) 1.61
Relationship of polymorphonuclear leukocytes to capillary dropout in the human diabetic choroid. Am J Pathol (1997) 1.58
Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. Invest Ophthalmol Vis Sci (1997) 1.46
Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals. Clin Exp Immunol (1997) 1.43
The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment. Invest Ophthalmol Vis Sci (1999) 1.42
Immunolocalization of TGF-beta 1, TGF-beta 2, and TGF-beta 3 in the anterior segment of the human eye. Invest Ophthalmol Vis Sci (1993) 1.40
The mechanism of optic nerve damage in experimental acute intraocular pressure elevation. Invest Ophthalmol Vis Sci (1980) 1.39
A surgically soft eye by posterior sclerotomy. Am J Ophthalmol (1966) 1.38
Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype. Invest Ophthalmol Vis Sci (1995) 1.37
Determination of the mechanism of free radical generation in human aortic endothelial cells exposed to anoxia and reoxygenation. J Biol Chem (1994) 1.35
Senescence-associated beta-galactosidase histochemistry for the primate eye. Invest Ophthalmol Vis Sci (1999) 1.32
Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis. J Immunol (1998) 1.32
Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T helper-1-like or a T helper-2-like response. J Immunol (1997) 1.31
A simplified dacryocystorhinostomy. 1954-1970. Arch Ophthalmol (1971) 1.28
Factors in the successful surgical management of basal cell carcinoma of the eyelids. Am J Ophthalmol (1981) 1.26
Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med (1998) 1.25
Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis. J Clin Invest (2000) 1.22
Establishment and characterization of a murine CD4+ T cell line and clone that induce experimental autoimmune uveoretinitis in B10.A mice. J Immunol (1996) 1.22
Glial retinal Müller cells produce IL-1 activity and have a dual effect on autoimmune T helper lymphocytes. Antigen presentation manifested after removal of suppressive activity. J Immunol (1988) 1.22
Organ-resident, nonlymphoid cells suppress proliferation of autoimmune T-helper lymphocytes. Science (1987) 1.17
IL-10 has a protective role in experimental autoimmune uveoretinitis. Int Immunol (1998) 1.16
Monoclonal antibodies against ICAM-1 (CD54) and LFA-1 (CD11a/CD18) inhibit experimental autoimmune uveitis. Clin Immunol Immunopathol (1993) 1.16
Vaso-obliteration in the canine model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci (1996) 1.15
Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis. Cell Immunol (1997) 1.15
Intrachoroidal microvascular abnormality: a previously unrecognized form of choroidal neovascularization. Am J Ophthalmol (1997) 1.15
IL-4 and IL-10 are both required for the induction of oral tolerance. J Immunol (1999) 1.11
Regulation of the interaction between Th1 and Th2 T cell clones to provide help for antibody production in vivo. Eur J Immunol (1995) 1.10
A new immunomodulating compound (AS-101) with potential therapeutic application. Nature (1987) 1.10
Altered distribution of basic fibroblast growth factor in diabetic retinopathy. Arch Ophthalmol (1991) 1.09
Pertussis toxin inhibits induction of tissue-specific autoimmune disease by disrupting G protein-coupled signals. J Immunol (2001) 1.07
Dual-perspective analysis of vascular formations in sickle cell retinopathy. Arch Ophthalmol (1993) 1.06
Increasing thyroid cancer incidence in Queensland, Australia 1982-2008 - true increase or overdiagnosis? Clin Endocrinol (Oxf) (2015) 1.05
Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye. J Immunol (1992) 1.04
βA3/A1-Crystallin controls anoikis-mediated cell death in astrocytes by modulating PI3K/AKT/mTOR and ERK survival pathways through the PKD/Bit1-signaling axis. Cell Death Dis (2011) 1.03
Clinical and histopathologic features of canine oxygen-induced proliferative retinopathy. Invest Ophthalmol Vis Sci (1998) 1.03
Vasoproliferation in the neonatal dog model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci (1996) 1.02
Localization of basic fibroblast growth factor to the developing capillaries of the bovine retina. J Cell Physiol (1989) 1.01
Residues 1-20 of IRBP and whole IRBP elicit different uveitogenic and immunological responses in interferon gamma deficient mice. Exp Eye Res (2000) 1.01
Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming. Invest Ophthalmol Vis Sci (1996) 1.01
A simplified, competitive RT-PCR method for measuring rat IFN-gamma mRNA expression. J Immunol Methods (1996) 1.00
Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. J Clin Invest (1994) 1.00
Angiogenic factors in human proliferative sickle cell retinopathy. Br J Ophthalmol (1999) 1.00
Measurement and characterization of free radical generation in reoxygenated human endothelial cells. Am J Physiol (1994) 0.99
Transgenic expression of an immunologically privileged retinal antigen extraocularly enhances self tolerance and abrogates susceptibility to autoimmune uveitis. Eur J Immunol (2000) 0.98
Visualization of a developing vasculature. Microvasc Res (1987) 0.98
Evaluation of in vivo cytokine expression in EAU-susceptible and resistant rats: a role for IL-10 in resistance? Exp Eye Res (2000) 0.97
Impaired expression of thrombospondin-1 in eyes with age related macular degeneration. Br J Ophthalmol (2006) 0.97
The acute intravenous toxicity of biological stains, dyes, and other fluorescent substances. Toxicol Appl Pharmacol (1978) 0.96
Presence of endothelial cell growth factor activity in normal and diabetic eyes. Curr Eye Res (1986) 0.96
Development of the human choriocapillaris. Eye (Lond) (2010) 0.96
Localization of adenosine A2a receptor in retinal development and oxygen-induced retinopathy. Invest Ophthalmol Vis Sci (2000) 0.95
Localisation of SDF-1 and its receptor CXCR4 in retina and choroid of aged human eyes and in eyes with age related macular degeneration. Br J Ophthalmol (2006) 0.94
Suppression of experimental autoimmune uveitis in mice by induction of anterior chamber-associated immune deviation with interphotoreceptor retinoid-binding protein. J Immunol (1992) 0.94
Vitreous: an inhibitor of retinal extract-induced neovascularization. Invest Ophthalmol Vis Sci (1983) 0.94
Adenosine stimulates canine retinal microvascular endothelial cell migration and tube formation. Curr Eye Res (1998) 0.93
Histopathologic features of neovascularization in sickle cell retinopathy. Am J Ophthalmol (1997) 0.92
Ocular structure and function in an aged monkey with spontaneous diabetes mellitus. Exp Eye Res (2005) 0.92
Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis. J Immunol (2000) 0.92
Postnatal retinal vascular development of the puppy. Invest Ophthalmol Vis Sci (1985) 0.91
Use of ACAID to suppress interphotoreceptor retinoid binding protein-induced experimental autoimmune uveitis. Curr Eye Res (1992) 0.91
Velocity measurements of normal and sickle red blood cells in the rat retinal and choroidal vasculatures. Microvasc Res (2000) 0.90
Pregnancy ameliorates induction and expression of experimental autoimmune uveitis. J Immunol (1999) 0.89
The control of astigmatism in cataract surgery. Trans Am Ophthalmol Soc (1967) 0.89
Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens. J Immunol (1993) 0.89
Immunohistochemical insights into sickle cell retinopathy. Curr Eye Res (1994) 0.88
Immunohistochemical localization of transforming growth factor-beta in human photoreceptors. Curr Eye Res (1991) 0.88
Angiogenic lymphokines of activated T-cell origin. Invest Ophthalmol Vis Sci (1983) 0.88
Autoimmunity to a pathogenic retinal antigen begins as a balanced cytokine response that polarizes towards type 1 in a disease-susceptible and towards type 2 in a disease-resistant genotype. Int Immunol (1999) 0.88
Retinal and choroidal neovascularization in a transgenic mouse model of sickle cell disease. Am J Pathol (1994) 0.87
A corneal micropocket assay for angiogenesis in the rat eye. Invest Ophthalmol Vis Sci (1981) 0.86
Neutrophils and leucocyte adhesion molecules in sickle cell retinopathy. Br J Ophthalmol (2002) 0.86
Predominant usage of V beta 8.3 T cell receptor in a T cell line that induces experimental autoimmune uveoretinitis (EAU). Clin Immunol Immunopathol (1992) 0.86